Conclusion
The diagnostic implications of integrated PET/CT imaging include improved detection of lesions on both the CT and FDG-PET images, better differentiation of physiologic from pathologic foci of metabolism, and better localization of the pathologic foci. This new powerful technology provides more-accurate interpretation of both CT and FDG-PET images and therefore moreoptimal patient care. PET/CT fusion images affect clinical management by guiding further procedures (biopsy, surgery, radiation therapy), excluding the need for additional procedures, and changing both inter- and intramodality therapy.
The combined approach of X-ray attenuation correction and image fusion with FDG imaging is a new and powerful diagnostic tool for nuclear medicine imaging, radiation therapy, and surgical planning. The applications for this technology, that have emerged with FDG as the radiotracer, will expand even further with the array of new promising PET tracers and in the field of cardiology.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Delbeke D, Martin WH, Patton JA, Sandler MP, editors. Practical FDG Imaging: A Teaching File. New York: Springer Verlag, 2002.
Cook GJR, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron emission tomography scanning: potential for error in interpretation. Semin Nucl Med 1996;26:308–314.
Engel H, Steinert H, Buck A, Berthold T, Boni RAH, von Schulthess GK. Whole body PET: physiological and artifactual fluorodeoxyglucose accumulations. J Nucl Med 1996;37:441–446.
Hutton BF, Braun M. Software for image registration: algorithms, accuracy, efficacy. Semin Nucl Med 2003;33(3):180–192.
Slomka PJ. Software approach to merging molecular with anatomic information. J Nucl Med 2004;45(suppl):36S–45S.
Townsend DW, Beyer T, Blodgett TM. PET/CT scanners: a hardware approach to image fusion. Semin Nucl Med 2003;33(3):193–204.
Townsend DW, Carney JPJ, Yap JT, Hall NC. PET/CT today and tomorrow. J Nucl Med 2004;45(suppl):4S–14S.
Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000;41:1369–1379.
Di Carli M. Advances in positron emission tomography. J Nucl Cardiol 2004;11(6):719–732.
Beyer T, Antoch G, Muller S, Egelhof T, Freudenberg LS, Debatin J, Bockisch A. Acquisition protocol considerations for combined PET/CT imaging. J Nucl Med 2004;45(suppl):25S–35S.
Kamel E, Hany TF, Burger, et al. CT vs. 68Ge attenuation correction in a combined PET/CT system: evaluation of the effect of lowering the CT current. Eur J Nucl Med Mol Imaging 2002;29:346–350.
Cohade C, Wahl RL. Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography: clinical use, interpretation methods, diagnostic improvements. Semin Nucl Med 2003;33(3):228–237.
Antoch G, Freudenberg LS, Beyer T, Bockisch A, Debatin JF. To enhance or not to enhance? 18F-FDG and CT contrast agents in dual modality 18F-FDG PET/CT. J Nucl Med 2004;45(suppl):56S–65S.
Antoch G, Freudenberg LS, Egeldorf T, et al. Focal tracer uptake: a potential artifact in contrasted-enhanced dual-modality PET/CT scans. J Nucl Med 2002;43:1339–1342.
Cohade C, Osman M, Nakamoto Y, et al. Initial experience with oral contrast in PET/CT: Phantom and clinical studies. J Nucl Med 2003;44:412–416.
Goerres GW, Hany TF, Kamel E, et al. Head and neck imaging with PET/CT: artifacts from dental metallic implants. Eur J Nucl Med Mol Imaging. 2002;29:367–370.
Dizendorf E, Hany TF, Buck A, et al. Cause and magnitude of the error induced by oral contrast agent in CT-based attenuation correction of PET emission studies. J Nucl Med 2003;44:732–738.
Goerres GW, Burger C, Schwitter MW, et al. PET/CT of the abdomen: optimizing the patient breathing pattern. Eur Radiol 2003;13:734–739.
Goerres GW, Burger C, Kamel E, et al. Respiration-induced attenuation artifact at PET/CT: technical considerations. Radiology 2003;226:906–910.
Cohade C, Osman M, Marshall LN, Wahl RN. PET/CT: accuracy of PET and CT spatial registration of lung lesions. Eur J Nucl Med Mol Imaging 2003;30:721–726.
Osman MM, Cohade C, Nakamoto Y, Wahl RH. Clinically significant inaccurate localization of lesions with PET/CT: frequency in 300 patients. J Nucl Med 2003;44:240–243.
Antoch G, Freudenberg LS, Beyer T, et al. To enhance or not to enhance? (18)F-FDG and CT contrast agents in dual-modality (18)F-FDG PET/CT. J Nucl Med 2004;45(I suppl):56S–65S.
Beyer T, Antoch G, Muller S, et al. Acquisition protocol considerations for combined PET/CT imaging. J Nucl Med 2004;45(I suppl):25S–35S.
Schaefer NG, Hany TF, Taverna C, Seifert B, Stumpe KD, von Schulthess GK, Goerres GW. Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging. Do we need contrast-enhanced CT? Radiology 2004;232(3):823–829.
Gambhir SS, Czernin J, Schimmer J, Silverman D, Coleman RE, Phelps ME. A tabulated summary of the FDG PET literature. J Nucl Med 2001;42(suppl):1S–93S.
Lerman H, Metser U, Grisaru D, Fishman A, Lievhitz G, Even-Sapir E. Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre-and postmenopausal patients: assessment by PET/CT. J Nucl Med 2004;45:266–271.
Erdi YE, Rosenzweig K, Erdi AK, et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol 2002;62:51–60.
Ciernik IF, Dizendorf E, Ciernik IF, Baumert B, et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. Int J Radiat Biol Phys 2003;57:853–863.
Bradley JD, Perez CA, Dehdashti F, Siegel BA. Implementing biological target volumes in radiation treatment planning for nonsmall cell lung cancer. J Nucl Med 2004;45(suppl I):96S–101S.
Charron M, Beyer T, Bohnen NN, et al. Image analysis in patients with cancer studied with a combined PET and CT scanner. Clin Nucl Med 2000;25:905–910.
Martinelli M, Townsend D, Meltzer C, Villemagne VV. Survey of results of whole body imaging using the PET/CT at the University of Pittsburgh Medical Center PET facility. Clin Posit Imaging 2000;3:161.
Bar-Shalom R, Yefremov N, Guralnik L, et al. Clinical performance of PET/CT in the evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med 2003;44:1200–1209.
Antoch G, Saoudi N, Kuehl H, Dahmen G, Mueller SP, Beyer T, et al.. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 2004;22(21):4357–4368.
Schoder H, Larson SM, Yeung HWD. PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies. J Nucl Med 2004;45(suppl):72S–81S.
Freudenberg LS, Antoch G, Schutt P, et al. FDG PET/CT in restaging of patients with lymphoma. Eur J Nucl Med Mol Imaging 2003;30:682–688.
Osman MM, Cohade C, Fishman EK, Wahl RL. Clinically significant incidental findings on the unenhanced CT portion of PET/CT studies: frequency in 250 patients. J Nucl Med 2005;46(8):1352–1355.
Barkhausen J, Dahmen G, Bockisch A, et al. Whole-body dualmodality PET/CT and whole body MRI for tumor staging in oncology. JAMA 2003;290(24):3199–3206.
Goerres GW, von Schultness GK, Hany TF. Positron emission tomography and PET CT of the head and neck: FDG uptake in normal anatomy, in benign lesions, and in changes resulting from treatment. Am J Roentgenol 2002;179:1337–1343.
Goerres GW, von Schulthess GK, Steinert HC. Why most PET of lung and head and neck cancer will be PET/CT. J Nucl Med 2004;45(suppl 1):66S–71S.
Schoder H, Yeung HW, Gonen M, Kraus D, Larson SM. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology 2004;231(1):65–72.
Lardinois D, Weder W, Hany TF, et al. Staging of non-small cell lung cancer with integrated positron-emission tomography and compared tomography. N Engl J Med 2003;348:2500–2507.
Antoch G, Stattaus J, Nemat AT, et al. Non-small cell lung cancer: dual modality PET/CT in preoperative staging. Radiology 2003;229(2):526–533.
Wahl RL. Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT. J Nucl Med 2004;45(suppl I):82S–95S.
Cohade C, Osman M, Leal J, Wahl RL. Direct comparison of FDG PET and PET/CT in patients with colorectal cancer. J Nucl Med 2003;44:1797–1803.
Kim WY, Daniass PG, Stuber M, et al. Coronary magnetic resonance angiography for detection of coronary stenoses. N Engl J Med 2001;345:1863–1869.
Schoepf UJ, Becker CR, Ohnesorge BM, Yucel EK. CT of coronary artery disease. Radiology 2004;232(1):18–37.
Schoenhagen P, Halliburton SS, Stillman AE, Kuzmiak SA, Nissen SE, Tuzcu EM, White RD. Noninvasive imaging of coronary arteries: current and future role of multidetector row CT. Radiology 2004; 232(1):7–17.
Rudd JH, Warburton EA, Fryer TD, et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002;105:2708–2711.
Namdar M, Hany TF, Koepfli P, Siegrist PT, Burger C, Wyss CA, Luscher TF, von Schulthess GK, Kaufmann PA. Integrated PET/CT for the assessment of coronary artery disease: a feasibility study. J Nucl Med 2005;46(6):930–935.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag London Limited
About this chapter
Cite this chapter
Delbeke, D. (2006). Incremental Value of Imaging Structure and Function. In: Valk, P.E., Delbeke, D., Bailey, D.L., Townsend, D.W., Maisey, M.N. (eds) Positron Emission Tomography. Springer, London . https://doi.org/10.1007/1-84628-187-3_2
Download citation
DOI: https://doi.org/10.1007/1-84628-187-3_2
Publisher Name: Springer, London
Print ISBN: 978-1-85233-971-5
Online ISBN: 978-1-84628-187-7
eBook Packages: MedicineMedicine (R0)